Hemab Therapeutics Holdings, Inc.(COAG)
Biotechnology
Rare Disease / Orphan Drug
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | RA Capital Healthcare Fund LP 10% Owner | Purchase | +67,669 | +1.06%6,444,637 | $24.97 | $1,689,818 | View SEC filing | |
| 2026-05-21 | RA Capital Healthcare Fund LP 10% Owner | Purchase | +4,798 | +0.08%6,376,968 | $24.96 | $119,776 | View SEC filing | |
| 2026-05-14 | RA Capital Healthcare Fund LP 10% Owner | Purchase | +6,387 | +0.10%6,372,170 | $24.90 | $159,036 | View SEC filing | |
| 2026-05-11 | RA Capital Healthcare Fund LP 10% Owner | Purchase | +51,258 | +0.81%6,365,783 | $24.75 | $1,268,594 | View SEC filing | |
| 2026-05-06 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +2,840,429 | +75.02%6,314,525 | $18.39 | $52,222,946 | View SEC filing |
1-5 of 5
Page 1 of 1